GAMBARAN POLA PERESEPAN OBAT COVID 19 RAWAT INAP DI RS PKU MUHAMMADIYAH SURAKARTA TAHUN 2020

Fahrizal, Sukma Pradana (2021) GAMBARAN POLA PERESEPAN OBAT COVID 19 RAWAT INAP DI RS PKU MUHAMMADIYAH SURAKARTA TAHUN 2020. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Fahrizal Sukma Pradana.pdf Restricted to Repository staff only Download (6MB)
	Text KTI.pdf Download (1MB)

Abstract

In 2019 was the beginning of the pandemic of coronavirus disease or COVID-19. Wolrd Health Organization (WHO) named the covid virus for the first time in patients affected by the novel coronavirus 2019 in Wuhan, China. Very quickly this virus spread and became a new outbreak that threatened the world. Positive patients in Indonesia until September 12, 2020, reached 214,746 confirmed cases, with the death toll reaching 8,650. PKU Muhammadiyah Surakarta Hospital has been a place for the treatment of COVID-19 patients who until October had treated 250 patients. Because specific therapy does not yet exist and the status of treatment is still being tested, this study aims to see the description of the medication for COVID-19 patients at the hospital. The research was a descriptive non-experimental study and the data was carried out retrospectively. The sampling technique used was purposive sampling technique, as many as 206 samples that met the inclusion standard. The most hospitalized COVID-19 patients from results showed that were Male sex was 54%, the most age group was 56-65 years of 27.67%, with the most comorbidities of hypertension by 25.89%, the most antiviral drug oseltamivir was 84.2%, the most indication of drugs was from the infectious drug class. amounted to 28.74%, and the most frequently used drug was omeprazole as many as 134 patients.

Actions (login required)

View Item